|

EB-DT-NK-UC101 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Beijing Biotech1

Indications

  • Locally Advanced Urothelial Carcinoma1
  • Upper Tract Urothelial Carcinoma1
  • Urothelial Carcinoma1
  • Bladder Cancer1
  • Metastatic Urothelial Carcinoma1

Other1 trial

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.